Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Short term Debt (2016 - 2023)

Marimed (MRMD) has disclosed Short term Debt for 9 consecutive years, with $3.6 million as the latest value for Q3 2023.

  • Quarterly Short term Debt changed N/A to $3.6 million in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $3.6 million through Sep 2023, changed N/A year-over-year, with the annual reading at $1.2 million for FY2020, 20.41% down from the prior year.
  • Short term Debt for Q3 2023 was $3.6 million at Marimed, roughly flat from $3.6 million in the prior quarter.
  • The five-year high for Short term Debt was $3.6 million in Q2 2023, with the low at $77157.0 in Q2 2019.
  • Average Short term Debt over 3 years is $1.6 million, with a median of $1.2 million recorded in 2020.
  • The sharpest move saw Short term Debt plummeted 62.36% in 2019, then skyrocketed 1703.22% in 2020.
  • Over 3 years, Short term Debt stood at $1.5 million in 2019, then decreased by 20.41% to $1.2 million in 2020, then soared by 210.93% to $3.6 million in 2023.
  • According to Business Quant data, Short term Debt over the past three periods came in at $3.6 million, $3.6 million, and $3.3 million for Q3 2023, Q2 2023, and Q1 2023 respectively.